title: Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism.
abstract: OBJECTIVE
  Patients with congenital hypothyroidism (CH) display subclinical abnormalities of the cardiovascular system that are related to unphysiological fluctuations of TSH levels and occur despite careful replacement therapy.
  
  
  METHODS
  The aim of the present case-control study was to evaluate the effects of long-term levothyroxine (l-T(4)) replacement therapy on the vascular district in CH patients by assessing endothelial function with flow-mediated dilation (FMD) and brachial artery distensibility with the measurement of the coefficient of distensibility (DC).
  
  
  METHODS
  Thirty-two young adults with CH aged 18.9+/-0.2 years and 32 age- and sex-matched controls underwent brachial Doppler ultrasound examination to measure FMD and DC at the time of the study. Hypothyroidism was diagnosed by neonatal screening, and l-T(4) treatment was initiated within the first month of life.
  
  
  RESULTS
  Compared to healthy controls, CH patients had significantly reduced brachial artery reactivity with lower FMD values (8.9+/-5.7 vs 14.1+/-5.1% P=0.003) and decreased vascular distensibility (24.6+/-1.6 vs 27.3+/-3 kPa(-1)x10(-3), P<0.0002). Linear regression analysis revealed that both total and pubertal mean TSH and number of episodes of undertreatment were independent determinants of FMD and DC. Pubertal mean TSH was the best predictor of both FMD and DC (r=0.81 and r=0.87 respectively, P<0.001).
  
  
  CONCLUSIONS
  Young adults with CH treated with long-term l-T(4) replacement therapy may have significant impairment of both FMD and DC. Our data suggest that high TSH levels, inadequately corrected by l-T(4) replacement therapy in CH patients especially during puberty, can exert significant effects on the elastic and functional vessel properties.
authors.affiliation: Department of Clinical Medicine, University Federico II, 80131 Naples, Italy.
authors.forename: Ugo
authors.initials: U
authors.lastname: Oliviero
authors.forename: Antonio
authors.initials: A
authors.lastname: Cittadini
authors.forename: Giorgio
authors.initials: G
authors.lastname: Bosso
authors.forename: Manuela
authors.initials: M
authors.lastname: Cerbone
authors.forename: Antonio
authors.initials: A
authors.lastname: Valvano
authors.forename: Donatella
authors.initials: D
authors.lastname: Capalbo
authors.forename: Valentina
authors.initials: V
authors.lastname: Apuzzi
authors.forename: Fabrizia
authors.initials: F
authors.lastname: Calabrese
authors.forename: Teresa
authors.initials: T
authors.lastname: Lettiero
authors.forename: Mariacarolina
authors.initials: M
authors.lastname: Salerno
mesh_terms: D000293:Adolescent; D050197:Atherosclerosis / Q000453:epidemiology*; D001916:Brachial Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000502:physiology; D016022:Case-Control Studies; D003409:Congenital Hypothyroidism / Q000188:drug therapy* / Q000453:epidemiology*; D004730:Endothelium, Vascular / Q000187:drug effects*; D005260:Female; D006801:Humans; D016014:Linear Models; D008137:Longitudinal Studies; D008297:Male; D011627:Puberty / Q000502:physiology; D012307:Risk Factors; D013974:Thyroxine / Q000008:administration & dosage*; D018608:Ultrasonography, Doppler; D014664:Vasodilation / Q000187:drug effects; D055815:Young Adult
chemical_list: D013974:Thyroxine